Adults with peanut allergies can be safely treated using exposure therapy to increase their resistance, new clinical trial results show. More than two-thirds of participants (67%) gained the ability to tolerate at least five peanuts without an immune reaction, researchers report in the journal Allergy. This is the first trial to test exposure therapy in…  read on >  read on >

The more ultra-processed food a person regularly eats, the higher their risk of an early death, a new evidence review has concluded. Each 10% increase in ultra-processed foods in a person’s diet increases their risk of early death from any cause by 3%, researchers reported today in the American Journal of Preventive Medicine. It’s estimated…  read on >  read on >

Women suffering from urinary incontinence might have a greater risk of heart disease, a new study says. Women who struggle with bladder control are more likely to have risk factors associated with heart health problems, including type 2 diabetes and high cholesterol, researchers reported in the Journal of Preventive Medicine. They also are more likely…  read on >  read on >

The Trump administration is expected to take new steps to remove artificial food dyes from the U.S. food supply, officials say. Health and Human Services Secretary Robert F. Kennedy Jr. and FDA Commissioner Dr. Marty Makary are expected to share more details on Tuesday, CNN reported. This follows a major move by the U.S. Food…  read on >  read on >

The U.S. Food and Drug Administration (FDA) may soon hand off routine food safety inspections to state and local officials, multiple federal health officials told CBS News. These changes are not final and could require approval and funding from Congress. Some FDA employees have been discussing a handoff for years. The goal is to free…  read on >  read on >

A new pill designed to help with weight loss and blood sugar control is showing promise in early studies. Eli Lilly said its experimental drug, orforglipron, helped people with type 2 diabetes lower their blood sugar and lose weight. The company is hoping to bring the first GLP-1 weight-loss pill to market, The Wall Street…  read on >  read on >